Chiasma Inc (CHMA) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Fri March 5th, 2021

- 05:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisChiasma (CHMA) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 01:34
  EarningsAnalysisChiasma, Inc. (CHMA) CEO Raj Kannan on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon February 22nd, 2021

- 13:00
  AnalysisChiasma: Undervalued Despite Approval And Market Potential Of MYCAPSSASeeking Alpha

Mon December 7th, 2020

- 22:25
  AnalysisChiasma Trades At A Big Discount To Fair Value With Mycapssa On The MarketSeeking Alpha

Wed December 2nd, 2020

- 11:48
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideRevisiting ChiasmaSeeking Alpha

Sat November 21st, 2020

- 13:41
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisStocks To Watch: Eyes On Best Buy, Vaccines And Holiday CheerSeeking Alpha

Sun November 8th, 2020

- 07:52
  EarningsAnalysisChiasma's (CHMA) CEO Raj Kannan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Fri November 6th, 2020

- 06:01
  EarningsAnalysisChiasma (CHMA) Q3 2020 Earnings Call TranscriptThe Motley Fool

Wed September 23rd, 2020

- 19:40
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  RumorsChiasma Inc (CHMA) on watch amid unconfirmed chatterStocktwits

Tue September 1st, 2020

- 17:35
  AnalysisCrinetics Pharmaceuticals- Superior Molecules In EndocrinologySeeking Alpha

Tue August 11th, 2020

- 06:30
  EarningsAnalysisChiasma (CHMA) Q2 2020 Earnings Call TranscriptThe Motley Fool
- 01:37
  EarningsAnalysisChiasma, Inc. (CHMA) CEO Raj Kannan on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon August 10th, 2020

- 22:35
  AnalysisStrongbridge Biopharma's Recorlev Phase 3 Topline Data Due September 2020 Is A Major Value Inflection PointSeeking Alpha

Wed July 1st, 2020

- 12:55
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisIs Chiasma (CHMA) Stock a Solid Choice Right Now?Zacks

Tue June 30th, 2020

- 16:31
  AnalysisChiasma's Valuation Should Be Higher Than $5-6/Share Now That Mycapssa Is FDA ApprovedSeeking Alpha

Mon June 29th, 2020

- 13:52
  AnalysisAre Options Traders Betting on a Big Move in Chiasma (CHMA) Stock?Zacks

Sun June 28th, 2020

- 19:34
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAcceleron's Sotatercept Trial, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Fri June 26th, 2020

- 12:28
  DigestThe Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street DebutsBenzinga

Sun June 21st, 2020

- 18:53
  The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA DecisionsBenzinga

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

About Developer Contact